Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis

Metabolism: Clinical and Experimental

Volumn 58, Issue 4, 2009, Pages 547-551

  Ebert, Thomas ^a   Bachmann, Anette ^a   Lössner, Ulrike ^a   Kratzsch, Jürgen ^a   Blüher, Matthias ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RELATED GROWTH FACTOR; GLUCOSE; GROWTH FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ANGIOPOIETINS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL DIALYSIS;

EID: 62349113882     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.11.016     Document Type: Article

References (14)

1. Fasshauer M., and Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 46 (2003) 1594-1603
2. Trujillo M.E., and Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27 (2006) 762-778
3. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
4. Kharitonenkov A., Shiyanova T.L., Koester A., et al. FGF-21 as a novel metabolic regulator. J Clin Invest 115 (2005) 1627-1635
5. Oike Y., Akao M., Yasunaga K., et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med 11 (2005) 400-408
6. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
7. Merabet E., Dagogo-Jack S., Coyne D.W., et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 82 (1997) 847-850
8. Seeger J., Ziegelmeier M., Bachmann A., et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 93 (2008) 247-251
9. Ziegelmeier M., Bachmann A., Seeger J., et al. Serum levels of the adipokine RBP-4 in relation to renal function. Diabetes Care 30 (2007) 2588-2592
10. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
11. Kratzsch J., Berthold A., Lammert A., et al. A rapid, quantitative immunofunctional assay for measuring human leptin. Horm Res 57 (2002) 127-132
12. Su Z., Korstanje R., Tsaih S.W., and Paigen B. Candidate genes for obesity revealed from a C57BL/6J x 129S1/SvImJ intercross. Int J Obes (Lond) 32 (2008) 1180-1189
13. Kitazawa M., Ohizumi Y., Oike Y., Hishinuma T., and Hashimoto S. Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/forkhead box class O1-dependent pathway in hepatocytes. J Pharmacol Exp Ther 323 (2007) 787-793
14. Zhang Y., and Scarpace P.J. The role of leptin in leptin resistance and obesity. Physiol Behav 88 (2006) 249-256